T1	Participants 74 119	patients with disseminated testicular tumors]
T2	Participants 358 402	patients with disseminated testicular tumors
T3	Participants 407 550	34 patients registered, 10 patients were with minimal disease in stages IIA, IIIO and IIIA and 24 with extensive disease in IIB, IIIB2 and IIIC
